Feasibility of classical secondary hormonal therapies prior to docetaxel therapy in Japanese patients with castration-resistant prostate cancer: Multicenter retrospective study

BACKGROUND: We retrospectively analyzed castration-resistant prostate cancer (CRPC) patients treated with secondary hormonal therapies (SHTs) prior to docetaxel therapy. METHODS: The cases of 73 CRPC patients who underwent docetaxel therapy in 2005–2011 at four hospitals in Ibaraki, Japan were analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandori, Shuya, Yoshino, Takayuki, Tsutsumi, Masakazu, Yamauchi, Atsushi, Ohtani, Mikinobu, Fukuhara, Yoshiharu, Miyanaga, Naoto, Miyazaki, Jun, Nishiyama, Hiroyuki, Shimazui, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153431/
https://www.ncbi.nlm.nih.gov/pubmed/27995113
http://dx.doi.org/10.1016/j.prnil.2016.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153431/
https://www.ncbi.nlm.nih.gov/pubmed/27995113
http://dx.doi.org/10.1016/j.prnil.2016.09.001

Ejemplares similares